Urokinase thrombolytic therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Iliac Vein Coronary Vessels Brain Middle Cerebral Artery Carotid Artery, Internal

Organisms2

Diseases39

Myocardial Infarction Stroke Pulmonary Embolism Brain Ischemia Cerebral Hemorrhage Thrombosis Acute Disease Hemorrhage Heart Rupture, Post-Infarction Intracranial Thrombosis Intracranial Hemorrhages Carotid Artery Thrombosis Coronary Thrombosis Intracranial Embolism and Thrombosis Recurrence Venous Thrombosis Emergencies Cerebral Infarction Intracranial Embolism Eye Hemorrhage Heart Rupture Infarction, Middle Cerebral Artery Arterial Occlusive Diseases Cerebrovascular Disorders Ecchymosis Shock, Cardiogenic Ventricular Septal Rupture Infarction, Anterior Cerebral Artery Thrombophlebitis Thromboembolism Embolism Ventricular Dysfunction, Right Heart Diseases Heart Block Disease Models, Animal Coronary Disease Ischemia Arrhythmias, Cardiac Constriction, Pathologic

Chemicals and Drugs32

Streptokinase Tissue Plasminogen Activator Fibrinolytic Agents Urokinase-Type Plasminogen Activator Receptors, Urokinase Plasminogen Activator Plasminogen Activators Anistreplase Heparin Fibrinolysin Plasminogen Recombinant Proteins Fibrin Receptors, Cell Surface Anticoagulants Fibrinogen Creatine Kinase Fibrinopeptide A Plasminogen Inactivators Plasminogen Activator Inhibitor 1 Fibrin Fibrinogen Degradation Products Streptodornase and Streptokinase Aspirin Antifibrinolytic Agents alpha-2-Antiplasmin Thrombin Hirudins Platelet Aggregation Inhibitors Plasminogen Activator Inhibitor 2 Enzyme Precursors Immunoglobulin Fab Fragments Thallium Radioisotopes Protease Nexins

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Thrombolytic Therapy Treatment Outcome Myocardial Reperfusion Embolectomy Electrocardiography Infusions, Intra-Arterial Angioplasty, Balloon, Coronary Prospective Studies Infusions, Intravenous Coronary Angiography Injections, Intravenous Tomography, X-Ray Computed Injections, Intra-Arterial Hirudin Therapy Emergency Treatment Thrombectomy Retrospective Studies Cerebral Angiography Radionuclide Ventriculography Hospital Mortality Reperfusion Follow-Up Studies Catheterization, Peripheral Patient Selection Survival Analysis Randomized Controlled Trials as Topic Angiography Prognosis Predictive Value of Tests Drug Therapy, Combination Risk Factors Cardiac Catheterization Survival Rate Multivariate Analysis Registries Catheterization Vena Cava Filters Severity of Illness Index Stroke Volume Angioplasty, Balloon Magnetic Resonance Imaging Hospitalization Double-Blind Method Incidence Logistic Models Heart Valve Prosthesis Disease Models, Animal Intra-Aortic Balloon Pumping Clinical Trials as Topic Fibrin Clot Lysis Time Combined Modality Therapy Treatment Failure Magnetic Resonance Angiography Ultrasonic Therapy Tomography, Emission-Computed, Single-Photon Drug Administration Schedule Ultrasonography, Doppler, Transcranial Echocardiography Length of Stay Sensitivity and Specificity Coronary Artery Bypass Regression Analysis Diffusion Magnetic Resonance Imaging Stents Risk Assessment Neurologic Examination

Phenomena and Processes12

Time Factors Fibrinolysis Vascular Patency Blood Coagulation Hemostasis Ventricular Function, Left Stroke Volume Coronary Circulation Cerebrovascular Circulation Fibrin Clot Lysis Time Sensitivity and Specificity Platelet Aggregation

Disciplines and Occupations1

Community Medicine

Information Science4

Hospital Mortality Survival Rate Registries Incidence

Named Groups1

Emergency Medical Technicians

Health Care34

Treatment Outcome Coronary Care Units Prospective Studies Emergency Medical Services Emergencies Retrospective Studies Emergency Medical Technicians Hospital Mortality Follow-Up Studies Patient Selection Survival Analysis Randomized Controlled Trials as Topic Predictive Value of Tests Risk Factors Hospitals, Community Survival Rate Multivariate Analysis Registries Severity of Illness Index Emergency Service, Hospital Hospitalization Double-Blind Method Incidence Logistic Models Clinical Trials as Topic Age Factors Treatment Failure Confounding Factors (Epidemiology)Length of Stay Sensitivity and Specificity Regression Analysis Drug Utilization Physician's Practice Patterns Risk Assessment

Geographicals1

Newfoundland and Labrador

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Thrombolytic Therapy Streptokinase Tissue Plasminogen Activator Fibrinolytic Agents Urokinase-Type Plasminogen Activator Receptors, Urokinase Plasminogen Activator Myocardial Infarction Plasminogen Activators Anistreplase Stroke Pulmonary Embolism Brain Ischemia Heparin Fibrinolysin Treatment Outcome Cerebral Hemorrhage Time Factors Fibrinolysis Myocardial Reperfusion Thrombosis Embolectomy Acute Disease Plasminogen Coronary Care Units Hemorrhage Heart Rupture, Post-Infarction Intracranial Thrombosis Intracranial Hemorrhages Electrocardiography Recombinant Proteins Fibrin Infusions, Intra-Arterial Carotid Artery Thrombosis Angioplasty, Balloon, Coronary Coronary Thrombosis Prospective Studies Intracranial Embolism and Thrombosis Infusions, Intravenous Recurrence Coronary Angiography Injections, Intravenous Vascular Patency Emergency Medical Services Venous Thrombosis Receptors, Cell Surface Tomography, X-Ray Computed Emergencies Cerebral Infarction Injections, Intra-Arterial Anticoagulants Intracranial Embolism Fibrinogen Hirudin Therapy Emergency Treatment Thrombectomy Creatine Kinase Retrospective Studies Emergency Medical Technicians Cerebral Angiography Radionuclide Ventriculography Hospital Mortality Reperfusion Fibrinopeptide A Follow-Up Studies Eye Hemorrhage Catheterization, Peripheral Plasminogen Inactivators Patient Selection Blood Coagulation Plasminogen Activator Inhibitor 1 Newfoundland and Labrador Survival Analysis Fibrin Fibrinogen Degradation Products Heart Rupture Randomized Controlled Trials as Topic Streptodornase and Streptokinase Aspirin Infarction, Middle Cerebral Artery Arterial Occlusive Diseases Angiography Prognosis Cerebrovascular Disorders Predictive Value of Tests Drug Therapy, Combination Ecchymosis Risk Factors Antifibrinolytic Agents Hospitals, Community Cardiac Catheterization Shock, Cardiogenic Ventricular Septal Rupture Hemostasis Survival Rate Infarction, Anterior Cerebral Artery Multivariate Analysis Registries Thrombophlebitis Catheterization alpha-2-Antiplasmin Iliac Vein

No FAQ available that match "urokinase thrombolytic therapy"